Eric E. Williams is an associate in the Indianapolis, Indiana office of Barnes & Thornburg LLP and a member of the firm's Intellectual Property Law Department. His practice is focused on preparing and prosecuting patent applications through the United States Patent and Trademark Office and counseling clients on the protection of intellectual property. He is a member of the firm's Food, Drug, and Device Law Practice Group, and in this regard has provided advice to multiple clients in the pharmaceutical industry and prepared patent term extension (PTE) applications for FDA-approved products.
Dr. Williams received his Doctor of Pharmacy degree from Purdue University in 2003 where he was a member of the Rho Chi Pharmacy Honor Society. At Purdue, he conducted research on the ErbB family of tyrosine kinase receptors. He is the co-author of four journal articles and several symposium abstracts published from this research. He is also a licensed pharmacist in the state of Indiana.
Upon graduation, Dr. Williams spent two years as a postdoctoral fellow in clinical research at the University of North Carolina-Chapel Hill and GlaxoSmithKline. At the University of North Carolina, he investigated CYP450 metabolism in various patient groups, including healthy volunteers, liver transplant donors, and liver transplant recipients. At GlaxoSmithKline, he participated in the design of Phase II/III clinical trials in the neuroscience therapeutic area, including interactions with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (formerly EMEA).
Dr. Williams also has experience as a medical information associate for Eli Lilly and Company. In this role, he provided support to Lilly's global affiliates and authored global response documents for Strattera® to answer clinical and regulatory product inquiries.
Dr. Williams earned his J.D. magna cum laude in 2009 from Indiana University School of Law - Indianapolis. In 2007, he served as a judicial clerk for the Honorable Matthew Kincaid of the Boone County Superior Court. While in law school, he was an articles editor of the Indiana Law Review and was a member of the Order of the Barristers. His student note, "Patent Reform: The Pharmaceutical Industry Prescription for Post-Grant Opposition and Remedies", was published in the Journal of the Patent and Trademark Office Society.
Events
· Maximizing Patent Term Adjustment: Prosecution Tips and Reconsideration Options in the Wake of Wyeth